(Q31151322)

29 June 2017

title

Microtiter cell-based assay for detection of agents that alter cellular levels of Her2 and EGFR. (English)

1 reference

29 June 2017

4

Gabriela Chiosis

0 references

author name string

Henri Huezo

series ordinal

1

1 reference

29 June 2017

Maria Vilenchik

series ordinal

2

1 reference

29 June 2017

Neal Rosen

series ordinal

3

1 reference

29 June 2017

publication date

1 July 2003

1 reference

29 June 2017

published in

Chemistry and Biology

1 reference

29 June 2017

volume

10

1 reference

29 June 2017

issue

7

1 reference

29 June 2017

page(s)

629-634

1 reference

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

29 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900144-3

7 January 2021

Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900144-3

7 January 2021

EGFR and cancer prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900144-3

7 January 2021

Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900144-3

7 January 2021

Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900144-3

7 January 2021

Untangling the ErbB signalling network

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900144-3

7 January 2021

The EGF receptor family as targets for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900144-3

7 January 2021

Drug-induced ubiquitylation and degradation of ErbB receptor tyrosine kinases: implications for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900144-3

7 January 2021

Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900144-3

7 January 2021

Geldanamycin as a potential anti-cancer agent: its molecular target and biochemical activity

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900144-3

7 January 2021

The benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycin

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900144-3

7 January 2021

Antibiotic radicicol binds to the N-terminal domain of Hsp90 and shares important biologic activities with geldanamycin

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900144-3

7 January 2021

A small molecule designed to bind to the adenine nucleotide pocket of Hsp90 causes Her2 degradation and the growth arrest and differentiation of breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900144-3

7 January 2021

Development of a purine-scaffold novel class of Hsp90 binders that inhibit the proliferation of cancer cells and induce the degradation of Her2 tyrosine kinase

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900144-3

7 January 2021

Novobiocin and related coumarins and depletion of heat shock protein 90-dependent signaling proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900144-3

7 January 2021

Modulation of p53, ErbB1, ErbB2, and Raf-1 expression in lung cancer cells by depsipeptide FR901228

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900144-3

7 January 2021

High-throughput screening of small molecules in miniaturized mammalian cell-based assays involving post-translational modifications

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900144-3

7 January 2021

A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900144-3

7 January 2021

Benzoquinoid ansamycins (herbimycin A and geldanamycin) interfere with the maturation of growth factor receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900144-3

7 January 2021

Measurement of protein using bicinchoninic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900144-3

7 January 2021

10.1016/S1074-5521(03)00144-3

Identifiers

DOI

1 reference

29 June 2017

1 reference